Tag: hereditary cancer testing market report

  • 2024-2033 Global Hereditary Cancer Testing Market Outlook: Projected Size and Growth Rate

    2024-2033 Global Hereditary Cancer Testing Market Outlook: Projected Size and Growth Rate

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    Hereditary Cancer Testing Market Growth Forecast 2024-2033: What’s the Expected Rate?

    The market size of hereditary cancer testing has been expanding rapidly in recent years. It is projected to increase from $3.97 billion in 2023 to $4.43 billion in 2024, with a compound annual growth rate (CAGR) of 11.6%. The significant growth that has been observed in the previous years can be traced back to several factors. These include the increasing occurrence of hereditary cancers, programs for genetic counseling, government initiatives aimed at preventing cancer, improved insurance coverage, a greater understanding of gene-environment interactions, as well as the contribution of patient advocacy and support groups.

    The market size of hereditary cancer testing is predicted to experience significant growth in the impending years, escalating to $6.7 billion in 2022 with a 10.9% compound annual growth rate (CAGR). Factors attributing to the growth during the projected period are the expansion of targeted therapies, progress made in precision medicine, increase in direct-to-consumer testing, global health initiatives, progress made in bioinformatics, etc. Forward-looking trends during the projection period include the evolution of genetic sequencing technologies, telemedicine, remote genetic counselling, personal treatment and precision medicine, cancer risk calculation models, and legal and ethical considerations.

    Claim Your Free Sample of the Global Hereditary Cancer Testing Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=8121&type=smp

    What Factors Are Impacting the Growth of the hereditary cancer testing Market?

    As the prevalence of hereditary cancer rises, so too does the hereditary cancer testing market. This particular form of cancer is caused by mutations in specific genes, inherited from parents to offspring. Testing for hereditary cancer is capable of pinpointing such inherited, disease-associated gene mutations, thereby providing patients with a thorough cancer risk evaluation. For example, an article in BioMed Central in June 2022 concerning hereditary cancer in clinical practice suggested that approximately 10% of pancreatic cancer instances have a genetic provenance. Additionally, SOPHiA Genetics, a data-driven medicine software firm based in Europe, mentioned in a May 2021 article that hereditary factors were responsible for roughly 10% of cancer cases, with an approximate 20% of cancer patients revealing a family history of the disease. Consequently, the escalating incidence of hereditary cancers adds fuel to the growth of the hereditary cancer testing market.

    What Are the Fundamental Segments in the Hereditary Cancer Testing Market?

    1) By Test Type: Multi Panel Test, Single-site Genetic Test

    2) By Indication: Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other Indications

    3) By End user: Hospital, Clinics, Diagnostic Centers

    What Trends Are Shaping the New Direction of the Hereditary Cancer Testing Market?

    The increasing adoption of technological advancements is a notable trend in the hereditary cancer testing market. Market leaders are centering on technological innovations to maintain their market standings. For example, in March 2022, the US-based genetic testing and precision medicine company, Myriad Genetics, introduced a genetic test that includes a Polygenic Breast Cancer Risk Assessment Score for all ancestries. Their MyRisk Hereditary Cancer test with RiskScore is providing a customized risk analysis for breast cancer to all women who have no prior history of breast cancer, irrespective of their ancestry.

    Order Now for Fast Delivery of Your Hereditary Cancer Testing Market Report!

    https://www.thebusinessresearchcompany.com/report/hereditary-cancer-testing-global-market-report

    North America was the largest region in the hereditary cancer testing market in 2023. The regions covered in the hereditary cancer testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Hereditary Cancer Testing Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the hereditary cancer testing market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Hereditary Cancer Testing Market Include

    1. Hereditary Cancer Testing Market Executive Summary

    2. Hereditary Cancer Testing Market Segments

    3. Hereditary Cancer Testing Market Size And Template Market Growth Rate

    4. Key Hereditary Cancer Testing Market Trends

    5. Major Hereditary Cancer Testing Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Hereditary Cancer Testing Market

    26. Top Hereditary Cancer Testing Companies

    27. Hereditary Cancer Testing Market Opportunities And Strategies

    28. Hereditary Cancer Testing Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Healthcare Analytical Testing Services Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/automatic-content-recognition-global-market-report

    Automotive Testing, Inspection And Certification Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/automotive-testing-inspection-and-certification-global-market-report

    Cold Plasma Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cold-plasma-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Overview Of The Hereditary Cancer Testing Market 2024-2033: Growth And Major Players Analysis

    Overview Of The Hereditary Cancer Testing Market 2024-2033: Growth And Major Players Analysis

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    The hereditary cancer testing market has experienced rapid growth driven by increasing awareness of hereditary cancers and advancements in genetic testing technologies. As the understanding of genetic predispositions to cancer expands, so does the demand for accurate and comprehensive testing solutions.

    Market Growth Trajectory

    • In 2023, the hereditary cancer testing market stood at $3.97 billion, set to surge to $4.43 billion in 2024, exhibiting a compound annual growth rate (CAGR) of 11.6%.
    • Historic growth factors include rising incidence of hereditary cancers, government initiatives, and improved insurance coverage.
    • Forecasts project significant expansion to $6.7 billion by 2028, fueled by advancements in precision medicine and global health initiatives.

    Rising Demand for Hereditary Cancer Testing

    • The increasing prevalence of hereditary cancer syndromes propels the demand for hereditary cancer testing.
    • Hereditary cancer testing enables the detection of specific gene mutations associated with increased cancer risk.
    • Approximately 10% of pancreatic cancer cases and 20% of cancer patients overall have a hereditary component.

    View More On The Hereditary Cancer Testing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/hereditary-cancer-testing-global-market-report

    Technological Innovations

    • Technological innovation is a key trend shaping the hereditary cancer testing market.
    • Companies like Myriad Genetics are pioneering cutting-edge approaches to genetic testing.
    • Myriad Genetics’ Polygenic Breast Cancer Risk Assessment Score offers personalized risk assessments for women.

    Strategic Acquisitions

    • Strategic acquisitions play a pivotal role in expanding companies’ genetic testing portfolios.
    • Exact Sciences’ acquisition of PreventionGenetics enhances its cancer testing capabilities and broadens its genetic testing portfolio.
    • PreventionGenetics brings comprehensive genetic testing capabilities and clinical expertise to Exact Sciences’ portfolio.

    Market Segmentation

    1. Test Type: Multi Panel Test, Single-site Genetic Test
    2. Indication: Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other Indications
    3. End User: Hospitals, Clinics, Diagnostic Centers

    Regional Dynamics

    • North America dominated the hereditary cancer testing market in 2023, driven by advanced healthcare infrastructure and awareness.
    • The market is witnessing significant growth in Asia-Pacific, fueled by increasing healthcare spending and awareness of hereditary cancer risks.

    Conclusion

    The hereditary cancer testing market is witnessing robust growth driven by advancements in genetic testing technologies and rising awareness of hereditary cancer risks. As companies invest in innovative testing solutions and expand their portfolios through strategic acquisitions, the market continues to evolve rapidly. With the advent of precision medicine and personalized treatment approaches, hereditary cancer testing plays a pivotal role in early detection and risk assessment. As the market expands, stakeholders must prioritize ethical considerations and ensure accessibility to testing for all individuals at risk. The future of hereditary cancer testing promises enhanced accuracy, broader applicability, and improved patient outcomes in the fight against cancer.

    Request A Sample Of The Global Hereditary Cancer Testing Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=8121&type=smp